Samina Hamied and Rumana Hamied, promoters of drug major Cipla, on Monday exited the pharmaceutical company by selling their 1.72 per cent ...

Cipla's shares are likely to attract attention on Monday as the company's promoters may sell up to a 1.72% stake through block deals. The o...

Cipla's vice-chairman MK Hamied has resigned from the board due to age and health concerns, effective October 29, 2024. His son Kamil Hamie...

Promoters of Cipla, including Person Acting in Concert, sold 2.04 crore shares in a block deal worth around Rs 2,600 crore to create liquid...

The move, days after the company posted its best annual results, has triggered speculation that more such transactions could be in the offi...

Samina Hamied, executive vice-chairperson of Cipla, announced her decision to step down from her executive role due to personal and family ...

Cipla's potential stake sale faces a challenge due to disagreements among its promoters regarding the company's valuation. This dispute amo...

Prospective buyers of a stake in Indian pharmaceutical company Cipla Ltd. are hesitant due to the high valuation demanded by the founding f...

"The Company will make appropriate disclosure in compliance with the Listing Regulations as and when any such requirement arises," the comp...

However, the company has issued a clarification, saying that "the company is not aware of any event that requires disclosure under Listing ...

Avadh Sugar, Dalmia Bharat Sugar and Magadh Sugar were the top gainers.

The stock moved 1.81 per cent higher to trade at Rs 476.50 on the NSE.

Drug major Cipla today announced completion of selling its entire holding in Hong Kong-based Biomab Holding to Biomab Brilliant for $ 2.5 m...

Shares of Cipla were today trading at Rs 648 per scrip in the afternoon trade on the BSE, up 1.27 per cent from its previous clsoe.

State-run Life Insurance Corporation has sold 2.12 per cent stake in drug manufacturer Cipla through open market transactions over a period...

The promoters of Cipla are in negotiations to sell their stake to a global buyer, according to investment banking sources familiar with the...

Cipla said it could take a decision to buy stake of up to 25 per cent in South Africa-based, Cipla Medpro in next board meeting. Cipla Medp...